-
Forecast of Global Medicine Spending Distribution in 2020 (by Region)
The U.S. and the European Union are expected to contribute around 54 percent of spending. Whereas, Brazil, Russia and India together are expected to c...
2018-05-21 09:59 -
Brief Introduction of Medicine
Contemporary medicine applies biomedical sciences, biomedical research, genetics, and medical technology to diagnose, treat, and prevent...
2018-05-21 09:31 -
Suven's Unit Completes USFDA Inspection
The plant is considered to be in an acceptable state of compliance with regard to current good manufacturing practices (cGMP) and the ag...
2018-05-17 13:33 -
Seppic and Ecovia Renewables Ink Bio-ingredients Collaboration Deal
“This partnership with Ecovia Renewables is fully aligned with Seppic strategy to design, develop and market ingredients that bring stro...
2018-05-17 12:10 -
Pharma Exports Can Cross $20-bn by 2020: Pharmexcil
India’s pharma exports to the US and North America, which contributed to over 30% of the country’s outbound shipments, dropped in 2017-1...
2018-05-17 11:44 -
Lonza to Invest in Expanding Biologics Capacity at US Site
“These new facilities have been designed specifically to deliver for our customers and their patients,” commented Marc Funk, COO Lonza Pharma & Biot...
2018-05-17 11:24 -
Infinion Biopharma Plans Rs. 100-cr. capex for Innovative Healthcare Technologie
It plans to set up a manufacturing and research facility in India. The company looks to develop innovative technologies for key therapeutic areas of d...
2018-05-17 11:18 -
Govt. Restricts Manufacture of Oxytocin for Domestic Use to Public Sector Only
The government has also banned the import of oxytocin and its formulations, besides bringing in some more regulations on the manufacture and sale of t...
2018-05-17 11:03 -
CSIR-NCL Develops an Anti-TB Co-crystal 4-FDC Drug with Improved Stability
The team studied the cause for the instability of the 4-FDC drug and discovered a pharmaceutically stable co-crystal by applying crystal engineering p...
2018-05-17 10:28 -
Cipla Receives Final Approval for Two Generic Drugs
Cipla’s Exemestane Tablets, 25 mg, is an AB-rated generic equivalent of Pfizer’s Aromasin, and is indicated for treatment of certain types of breast...
2018-05-17 10:09
Hot News
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- BASF Launches Second Round of ... Jul 24, 2025
- Corning Acquires JA Solar’s $... Jul 30, 2025
- Sun Pharma Halts US Expansion ... Aug 03, 2025
Related Products
Related Producers
